An in vitro system for the leader-primed transcription of coronavirus mRNAs
- PMID: 2174358
- PMCID: PMC552193
- DOI: 10.1002/j.1460-2075.1990.tb07641.x
An in vitro system for the leader-primed transcription of coronavirus mRNAs
Abstract
We have developed an in vitro transcription system which can utilize exogenous leader RNA for mouse hepatitis virus (MHV) 'leader-primed' mRNA transcription. Cytoplasmic extracts containing viral proteins and template RNA were prepared by lysolecithin permeabilization of MHV-infected cells. Synthetic leader RNA which differed in sequence from the endogenous leader RNA was added to the extracts and demonstrated to be incorporated into MHV mRNAs. Irrespective of the size of leader RNAs added, the exogenous leader RNA was joined to the endogenous mRNA at the same site, which corresponds to a UCUAA pentanucleotide repeat region. Only leader RNAs containing the pentanucleotide sequences could be utilized for transcription. Mismatches between the intergenic site and the exogenous leader sequence within the pentanucleotide repeat region were corrected in the in vitro system. This in vitro system thus established a novel mechanism of leader-primed transcription using exogenous RNA in trans, and suggests the involvement of a specific ribonuclease activity during coronavirus mRNA synthesis.
Similar articles
-
Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis.J Virol. 1994 Aug;68(8):4738-46. doi: 10.1128/JVI.68.8.4738-4746.1994. J Virol. 1994. PMID: 8035476 Free PMC article.
-
Evolution of the 5'-end of genomic RNA of murine coronaviruses during passages in vitro.Virology. 1989 Mar;169(1):227-32. doi: 10.1016/0042-6822(89)90060-3. Virology. 1989. PMID: 2538033 Free PMC article.
-
A system for study of coronavirus mRNA synthesis: a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion.J Virol. 1991 Nov;65(11):6031-41. doi: 10.1128/JVI.65.11.6031-6041.1991. J Virol. 1991. PMID: 1656085 Free PMC article.
-
Coronavirus leader-RNA-primed transcription: an alternative mechanism to RNA splicing.Bioessays. 1986 Dec;5(6):257-60. doi: 10.1002/bies.950050606. Bioessays. 1986. PMID: 3551939 Free PMC article. Review.
-
A new model for coronavirus transcription.Adv Exp Med Biol. 1998;440:215-9. doi: 10.1007/978-1-4615-5331-1_26. Adv Exp Med Biol. 1998. PMID: 9782283 Review.
Cited by
-
Viral and cellular proteins involved in coronavirus replication.Curr Top Microbiol Immunol. 2005;287:95-131. doi: 10.1007/3-540-26765-4_4. Curr Top Microbiol Immunol. 2005. PMID: 15609510 Free PMC article. Review.
-
Function of a 5'-end genomic RNA mutation that evolves during persistent mouse hepatitis virus infection in vitro.J Virol. 1995 Dec;69(12):7529-40. doi: 10.1128/JVI.69.12.7529-7540.1995. J Virol. 1995. PMID: 7494259 Free PMC article.
-
Dissecting RNA recombination in vitro: role of RNA sequences and the viral replicase.EMBO J. 1998 Apr 15;17(8):2392-403. doi: 10.1093/emboj/17.8.2392. EMBO J. 1998. PMID: 9545250 Free PMC article.
-
Phylogenetic and antigenic analysis of avian infectious bronchitis virus in southwestern China, 2012-2016.Infect Genet Evol. 2016 Nov;45:11-19. doi: 10.1016/j.meegid.2016.08.011. Epub 2016 Aug 13. Infect Genet Evol. 2016. PMID: 27530216 Free PMC article.
-
PRRSV structure, replication and recombination: Origin of phenotype and genotype diversity.Virology. 2015 May;479-480:475-86. doi: 10.1016/j.virol.2015.02.012. Epub 2015 Mar 7. Virology. 2015. PMID: 25759097 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources